Analysis Metabolite Name Measured Value Units Group
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.1638Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.2904Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.2999Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.3310Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.3428Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.4243Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.4395Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.4411Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.4490Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.4625Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.4825Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.5116Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.5213Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.5461Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.5526Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.5696Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.5904Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.6243Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.6611Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.6671Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.6852Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.6968Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.7049Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.7116Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.7197Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.7216Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.7300Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.7311Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.7327Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.7450Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.7535Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.7595Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.7751Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.7865Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.7904Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.7998Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.8126Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.8145Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.8157Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.8272Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.8350Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.8366Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.8376Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.8376Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.8388Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.8479Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.8593Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.8712Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.8729Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.8746Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.8817Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.8845Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.8895Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.9227Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.9280Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.9404Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.9410Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.9468Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.9565Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.9581Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.9690Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.9701Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.9799Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.9894Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)0.9981Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.0000Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.0001Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.0075Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.0094Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.0257Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.0294Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.0321Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.0455Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.0479Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.0515Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.0642Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.0760Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.0818Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.0907Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.0912Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.0953Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.0981Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.1007Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.1252Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.1296Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.1369Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.1431Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.2011Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.2096Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.2124Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.2171Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.2173Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.2248Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.2381Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.2399Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.2473Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.2598Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.2602Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.2699Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.2717Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.2753Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.3031Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.3032Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.3352Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.3645Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.3780Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.3915Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.4046Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.4342Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.4439Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.4610Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.4678Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.4923Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.5115Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.5733Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.6242Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.6400Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.6496Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.6584Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.6611Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.6722Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.6938Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.7054Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.7240Peak areaLean
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.7558Peak areaObese neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.8585Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.8764Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.9052Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)1.9784Peak areaObese non neuropathy
Reversed phase POSITIVE ION MODElinoleate (18:2n6)2.1155Peak areaObese neuropathy

Return to search page
  logo